About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Maryland | 572 Studies

Clinical Trials LymphomaMaryland

Lymphoma Clinical Trials in Maryland

Find 572 clinical trials for lymphoma near Maryland. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 572 trials

UnknownSafety Study of CAT-8015 Immunoxin in Patients With NHL With Advance DiseaseRATIONALE: The CAT-8015 immunotoxin can bind tumor cells and kill them without harming normal cells.NCT00515892·Beverly Hills, California and 2 others CompletedA Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of OrganochlorinesNon-Hodgkin's lymphoma (NHL) is the third most rapidly increasing cancer in the United States. HIV-related NHL is responsible for some of the increase since the early 1980s.NCT00001571·Bethesda, Maryland

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedA Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell TransplantationHigh-dose chemotherapy followed by blood stem cell transplantation is administered to lymphoma patients with an intention to cure.NCT05181540·Gilbert, Arizona and 27 others

CompletedInvestigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and CancerThis protocol is being submitted to consolidate, update, and expand two previously approved protocols (77-C-0066 and 82-C-0044) into a single protocol.NCT00001582·Bethesda, Maryland

CompletedAdministration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell TransplantationBackground: * Allogeneic hematopoietic stem cell transplantation (alloHSCT) is a procedure that transplants bone marrow cells (stem cells) from a matching donor into a recipient…NCT01087294·Bethesda, Maryland and 1 other

CompletedPhase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary SyndromeBackground: Adult T-cell leukemia/lymphoma (ATLL) and mycosis fungoides/Sezary syndrome (MF/SS) are cancers that form in the T cells, a type of white blood cell that helps with…NCT04185220·Bethesda, Maryland

CompletedPilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell LymphomasMajor improvements in the treatment of childhood non-lymphoblastic lymphomas have taken place in the last ten years.NCT00001237·Bethesda, Maryland

TerminatedStudy to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular LymphomaEvaluate the safety and tolerability of AMG 562 in adult subjects with DLBCL, MCL, or FL.NCT03571828·Duarte, California and 11 others

CompletedVaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular LymphomaRATIONALE: Vaccines made from a person's cancer cells may make the body build an immune response to kill tumor cells.NCT00020462·Bethesda, Maryland

CompletedFR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaThis phase II trial is studying how well FR901228 works in treating patients with relapsed or refractory non-Hodgkin's lymphoma.NCT00077194·Washington D.C., District of Columbia and 3 others

TerminatedGRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host DiseaseThe purpose of this study is to assess the impact and safety of itacitinib in combination with calcineurin inhibitor (CNI)-based interventions for the prophylaxis of…NCT03320642·Aurora, Colorado and 16 others

AvailableExpanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene CiloleucelThe goal of this study is to provide access to axicabtagene ciloleucel for patients diagnosed with a disease approved for treatment with axicabtagene ciloleucel, that is otherwise…NCT05776160·Birmingham, Alabama and 127 others

CompletedStudy of MLN8237 in Participants With Advanced Hematological MalignanciesThis is an open-label, multicenter, phase 1 study of MLN8237 in participants with advanced hematological malignancies for whom there are limited standard treatment options.NCT00697346·Scottsdale, Arizona and 9 others

CompletedFenretinide in Treating Patients With Refractory or Relapsed Hematologic CancerRATIONALE: Drugs used in chemotherapy, such as fenretinide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from…NCT00104923·Los Angeles, California and 3 others

TerminatedOptimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and RituximabThis phase II trial is studying how well giving fludarabine and cyclophosphamide together with total-body irradiation and rituximab works in treating patients with B-cell lymphoma…NCT00946023·Baltimore, Maryland

CompletedGallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002543·Baltimore, Maryland and 2 others

CompletedCollecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin LymphomaThis research study is collecting and storing samples of bone marrow and blood from patients with relapsed acute lymphoblastic leukemia or relapsed non-Hodgkin lymphoma.NCT00897325·Birmingham, Alabama and 182 others

TerminatedFR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's LymphomaThis phase I/II trial is studying the best dose of FR901228 when given together with rituximab and fludarabine and to see how well FR901228 works alone in treating patients with…NCT00079443·Baltimore, Maryland

Active not recruitingTrial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell MalignanciesBackground: About 23,000 people die from B-cell cancers in the US each year. These cancers, often called leukemia or lymphoma, affect a type of white blood cell called B cells.NCT05797233·Bethesda, Maryland

RecruitingTesting Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial ChemotherapyThis phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with peripheral T-cell lymphoma…NCT06724237·Birmingham, Alabama and 164 others

Page 1 of 29Next

Other Conditions in Maryland

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia